FDA Approves Arcutis’ Zoryve® (Roflumilast) Cream 0.15% for the Treatment of Atopic Dermatitis in Adults and Children Down to 6 Years of Age
FDA批准Arcutis的Zoryve® (Roflumilast)霜0.15%用于治疗儿童至6岁及成人的特应性皮炎
FDA Approves Arcutis’ Zoryve® (Roflumilast) Cream 0.15% for the Treatment of Atopic Dermatitis in Adults and Children Down to 6 Years of Age
FDA批准Arcutis的Zoryve® (Roflumilast)霜0.15%用于治疗儿童至6岁及成人的特应性皮炎
使用浏览器的分享功能,分享给你的好友吧